真空采血市场 - 全球产业规模、份额、趋势、机会及预测（按类型、应用、最终用途、地区和竞争格局划分，2021-2031年）

全球真空采血市场预计将从 2025 年的 32.6 亿美元成长到 2031 年的 41.1 亿美元，复合年增长率为 3.94%。

该行业主要从事无菌真空采血管的生产和供应，这些采血管可用于采集特定量的血液样本以进行诊断。该市场的成长主要受以下因素驱动：全球慢性病发病率的上升，这些疾病需要频繁进行血液学检测；以及为保护医护人员免受针刺伤而严格执行的安全通讯协定。对准确诊断结果的基本需求也支撑着这一成长。例如，国际糖尿病联盟 (IDF) 报告称，到 2024 年，全球约有 5.89 亿成年人患有糖尿病。如此庞大的患者群体将需要大量的血液检测，从而持续推动对可靠采血设备的需求。

然而，市场扩张的主要障碍包括开发中国家熟练采血师短缺和检查室基础设施不足。缺乏使用先进真空系统的专业人员常常导致检体错误和溶血，从而影响诊断准确性。这种技术专长的缺乏，加上资源匮乏地区预算的限制，阻碍了高品质、安全产品的引入，限制了这些地区的市场渗透率。

市场驱动因素

慢性病和感染疾病的日益普及是全球真空采血市场的主要驱动因素。癌症等慢性病需要持续的血液学监测，这显着增加了采血频率和无菌真空采血管的使用。根据美国癌症协会发布的《2024年癌症事实与数据》，预计2024年美国将新增2,001,140例癌症病例，这将导致大规模的患者群体需要反覆诊断和可靠的采血设备。此外，感染疾病防治工作日益繁重，也需要广泛采集血液样本以进行有效管理。泛美卫生组织的报告显示，2024年美洲将确诊超过930万例登革热病例，凸显了在传染病爆发期间高效采血工具的重要性。

推动市场渗透的另一个关键因素是预防性护理和疾病早期筛检需求的激增。医疗卫生系统日益重视早期检测，以降低未治疗疾病的长期成本，因此，许多采用真空采集技术的筛检计画应运而生。这一趋势在病毒感染疾病的管理中尤其重要，因为及时诊断是治疗的关键。例如，根据世界卫生组织（世卫组织）发布的《2024年全球肝炎报告》，预计2022年，将有2.54亿人感染B型肝炎。该族群中大量未确诊病例促使人们努力扩大筛检覆盖范围，从而增加了对安全可靠的真空采集系统的需求，以确保检体的完整性。

市场挑战

全球真空采血市场，尤其是在开发中国家，主要受限于熟练采血员短缺和检查室基础设施不足。先进的真空系统需要精准阻碍因素才能维持适当的血液与添加剂比例，确保检体完整性。在技​​术专长有限的地区，这些设备的使用不当常常导致检体溶血和体积误差，进而影响诊断准确性。如此高的故障率阻碍了资源匮乏地区医疗机构升级到安全可靠的高品质真空采血管，导致他们仍然依赖不可靠的传统方法，并阻碍了这些关键增长地区的市场渗透。

近期反映整个产业不稳定的数据凸显了人才短缺的严重性。根据美国临床病理学会 (ASCP) 发布的《2024 年报告》，临床实验室持续面临严重的员工短缺问题，部分部门的空缺率高达 28.5%。合格人员的长期匮乏限制了诊断机构的诊疗运作，并严重阻碍了专业采血技术的广泛应用。

市场趋势

基因组学和精准医疗专用试管的研发正显着影响着产业产品创新。随着液态生物检体应用范围的不断扩大，迫切需要能够稳定游离DNA并防止运输过程中基因组污染的血液采集装置。这一需求不同于标准血液学检测，它优先考虑核酸的保存以进行分子分析，并推动了高价值、添加防腐剂的试管的生产。例如，Guardant Health于2024年8月发布的「2024年第二季财务业绩报告」指出，其生物製药检测量年增56%，这反映出其精准肿瘤学平台的应用日益广泛，而该平台正是依赖此类先进的血液采集技术。

同时，面向消费者的直接检测和居家检测解决方案的普及正在使血液检体采集分散化。这一趋势推动了毛细血管采血设备的使用，该设备可在零售店和偏远地区进行微创、小容量的血液采集，从而减少对传统静脉穿刺的依赖。透过使患者能够在临床环境之外获得诊断服务，製造商正在开拓以消费者为中心的新市场领域。 2024年3月，Babson Diagnostics宣布其「BetterWay」生态系统正式上市，并计划在年底前将其部署到100多家零售药局，以协助实现便利的小容量血液采集。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球真空采血市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（血清分离管、血浆分离管、EDTA管、快速血清管、凝血管等）
  • 依应用领域（血清学/免疫学、一般血液检查、血液凝固检验、基因研究、血糖测量等）
  • 依最终用途（医院/诊所、病理检查室、血库）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美真空采血市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲真空采血市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区真空采血市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲真空采血市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲真空采血市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球真空采血市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Sekisui Chemical Co., Ltd
• Becton, Dickinson and Company
• Cardinal Health, Inc.
• Greiner AG
• Advin Health Care
• AdvaCare Pharma
• Hindustan Syringes & Medical Devices Ltd
• MB Plastic Industries
• Biota
• Streck LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Vacuum Blood Collection Market is projected to expand from a valuation of USD 3.26 Billion in 2025 to USD 4.11 Billion by 2031, registering a compound annual growth rate of 3.94%. This industry involves the manufacture and supply of sterile evacuated tubes capable of drawing specific volumes of blood for diagnostic purposes. The market is largely driven by the rising global incidence of chronic diseases, which demands frequent hematological assessments, as well as the strict enforcement of safety protocols designed to protect healthcare workers from needlestick injuries. The fundamental need for precise diagnostic results underpins this growth; for instance, the International Diabetes Federation reported in 2024 that approximately 589 million adults worldwide were living with diabetes, a vast patient base that necessitates high volumes of blood work and sustains the demand for dependable collection devices.

However, a major obstacle hindering broader market expansion is the shortage of skilled phlebotomists and insufficient laboratory infrastructure in developing nations. The absence of trained professionals proficient in using advanced vacuum systems often results in sample errors and hemolysis, jeopardizing diagnostic accuracy. This lack of technical expertise, coupled with budgetary limitations in low-resource environments, restricts the adoption of premium safety-engineered products and limits market penetration in these regions.

Market Driver

The escalating prevalence of chronic and infectious diseases acts as a primary catalyst for the Global Vacuum Blood Collection Market. Chronic conditions such as cancer necessitate continuous hematological monitoring, which significantly increases the frequency of blood draws and the use of sterile vacuum tubes. According to the American Cancer Society's 'Cancer Facts & Figures 2024', the United States was expected to see 2,001,140 new cancer cases in 2024, creating a large patient pool requiring repeated diagnostics and reliable collection equipment. Additionally, the burden of infectious diseases demands extensive blood sampling for effective management; the Pan American Health Organization reported over 9.3 million dengue cases in the Americas in 2024, highlighting the critical need for efficient collection tools during communicable disease outbreaks.

Another key factor propelling market adoption is the surging demand for preventive healthcare and early disease screening. Health systems are increasingly prioritizing early detection to mitigate the long-term costs associated with untreated illnesses, leading to numerous screening programs that utilize vacuum-based collection methods. This trend is especially vital for managing viral infections where timely diagnosis is essential for treatment. For example, the World Health Organization's 'Global Hepatitis Report 2024' estimated that 254 million people were living with hepatitis B in 2022. The high number of undiagnosed individuals within this population drives initiatives to expand screening coverage, thereby boosting the demand for safety-engineered vacuum systems to ensure sample integrity.

Market Challenge

A significant restraint on the Global Vacuum Blood Collection Market, particularly in developing economies, is the scarcity of skilled phlebotomists and inadequate laboratory infrastructure. Advanced vacuum systems require precise handling to maintain the correct blood-to-additive ratio and ensure sample integrity. In regions where technical expertise is limited, the improper use of these devices frequently results in sample hemolysis or volume errors, which undermines diagnostic accuracy. This high failure rate often discourages healthcare institutions in low-resource settings from upgrading to premium, safety-engineered vacuum tubes, leading them to rely on traditional, less reliable methods and stifling market penetration in these critical growth areas.

The severity of this workforce challenge is underscored by recent data reflecting broader industry instability. As reported by the American Society for Clinical Pathology in 2024, the clinical laboratory sector continued to struggle with severe staffing shortages, with vacancy rates in some departments reaching as high as 28.5%. This chronic lack of qualified personnel limits the operational capacity of diagnostic facilities and creates a substantial barrier to the widespread adoption of specialized blood collection technologies.

Market Trends

Product innovation in the industry is being significantly shaped by the development of specialized tubes for genomic and precision medicine. As liquid biopsy applications grow, there is a critical need for collection devices that can stabilize cell-free DNA and prevent genomic contamination during transport. This requirement is distinct from standard hematology, prioritizing the preservation of nucleic acids for molecular analysis and driving the production of high-value, preservative-enhanced tubes. For instance, Guardant Health's 'Second Quarter 2024 Financial Results' in August 2024 noted a 56% year-over-year increase in biopharmaceutical test volumes, reflecting the rising adoption of precision oncology platforms that depend on these advanced collection technologies.

Simultaneously, the landscape of blood sample collection is being decentralized by the expansion of direct-to-consumer and home-based testing solutions. This trend encourages the use of capillary blood collection devices that facilitate minimally invasive, low-volume sampling in retail or remote settings, reducing the reliance on traditional venipuncture. By enabling patients to access diagnostic services outside of clinical facilities, manufacturers are tapping into a new consumer-centric market segment. In March 2024, Babson Diagnostics announced the commercial launch of its BetterWay ecosystem, planning deployment in over 100 retail pharmacy locations by the end of the year to support convenient, small-volume blood collection.

Key Market Players

• Sekisui Chemical Co., Ltd
• Becton, Dickinson and Company
• Cardinal Health, Inc.
• Greiner AG
• Advin Health Care
• AdvaCare Pharma
• Hindustan Syringes & Medical Devices Ltd
• MB Plastic Industries
• Biota
• Streck LLC

Report Scope

In this report, the Global Vacuum Blood Collection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vacuum Blood Collection Market, By Type

• Serum Separating Tubes
• Plasma Separation Tubes
• EDTA Tubes
• Rapid Serum Tubes
• Coagulation Tubes
• Others

Vacuum Blood Collection Market, By Application

• Serology & Immunology
• Blood Routine Examination
• Coagulation Tests
• Genetic Studies
• Blood Sugar Assay
• Others

Vacuum Blood Collection Market, By End-use

• Hospitals & Clinics
• Pathology Laboratories
• Blood Banks

Vacuum Blood Collection Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vacuum Blood Collection Market.

Available Customizations:

Global Vacuum Blood Collection Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vacuum Blood Collection Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Serum Separating Tubes, Plasma Separation Tubes, EDTA Tubes, Rapid Serum Tubes, Coagulation Tubes, Others)
  • 5.2.2. By Application (Serology & Immunology, Blood Routine Examination, Coagulation Tests, Genetic Studies, Blood Sugar Assay, Others)
  • 5.2.3. By End-use (Hospitals & Clinics, Pathology Laboratories, Blood Banks)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Vacuum Blood Collection Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End-use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vacuum Blood Collection Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-use
  • 6.3.2. Canada Vacuum Blood Collection Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-use
  • 6.3.3. Mexico Vacuum Blood Collection Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-use

7. Europe Vacuum Blood Collection Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End-use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Vacuum Blood Collection Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-use
  • 7.3.2. France Vacuum Blood Collection Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-use
  • 7.3.3. United Kingdom Vacuum Blood Collection Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-use
  • 7.3.4. Italy Vacuum Blood Collection Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-use
  • 7.3.5. Spain Vacuum Blood Collection Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-use

8. Asia Pacific Vacuum Blood Collection Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End-use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Vacuum Blood Collection Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-use
  • 8.3.2. India Vacuum Blood Collection Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-use
  • 8.3.3. Japan Vacuum Blood Collection Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-use
  • 8.3.4. South Korea Vacuum Blood Collection Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-use
  • 8.3.5. Australia Vacuum Blood Collection Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-use

9. Middle East & Africa Vacuum Blood Collection Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End-use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Vacuum Blood Collection Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-use
  • 9.3.2. UAE Vacuum Blood Collection Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-use
  • 9.3.3. South Africa Vacuum Blood Collection Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-use

10. South America Vacuum Blood Collection Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End-use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Vacuum Blood Collection Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-use
  • 10.3.2. Colombia Vacuum Blood Collection Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-use
  • 10.3.3. Argentina Vacuum Blood Collection Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Vacuum Blood Collection Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Sekisui Chemical Co., Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. Cardinal Health, Inc.
• 15.4. Greiner AG
• 15.5. Advin Health Care
• 15.6. AdvaCare Pharma
• 15.7. Hindustan Syringes & Medical Devices Ltd
• 15.8. MB Plastic Industries
• 15.9. Biota
• 15.10. Streck LLC

16. Strategic Recommendations

17. About Us & Disclaimer